• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝吸虫相关胆管癌的特征:药物靶点的可能性洞察。

The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility.

机构信息

Department of System Biosciences and Computational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand.

Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, 40002, Thailand.

出版信息

Recent Results Cancer Res. 2023;219:53-90. doi: 10.1007/978-3-031-35166-2_4.

DOI:10.1007/978-3-031-35166-2_4
PMID:37660331
Abstract

Cholangiocarcinoma (CCA) is a malignant tumor of the biliary tree that is classified into three groups based on its anatomic location: intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA). Perihilar CCA is the most common type and accounts for 50-60% of CCA cases. It is followed by distal CCA and then intrahepatic CCA that account for 20-30% and 10-20% of cases, respectively. This chapter discusses the hallmarks of liver fluke related CCA and explores insights into drug target possibilities.

摘要

胆管癌(CCA)是一种源于胆道的恶性肿瘤,根据其解剖位置可分为三组:肝内(iCCA)、肝门周围(pCCA)和远端(dCCA)。肝门周围 CCA 最常见,占 CCA 病例的 50-60%。其次是远端 CCA,然后是肝内 CCA,分别占 20-30%和 10-20%。本章讨论了与肝吸虫相关的 CCA 的特征,并探讨了药物靶点的可能性。

相似文献

1
The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility.肝吸虫相关胆管癌的特征:药物靶点的可能性洞察。
Recent Results Cancer Res. 2023;219:53-90. doi: 10.1007/978-3-031-35166-2_4.
2
Novel Targeted Therapies for Advanced Cholangiocarcinoma.晚期胆管癌的新型靶向治疗
Medicina (Kaunas). 2021 Feb 26;57(3):212. doi: 10.3390/medicina57030212.
3
Cholangiocarcinoma miscoding in hepatobiliary centres.肝胆中心胆管癌错配。
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):635-639. doi: 10.1016/j.ejso.2020.09.039. Epub 2020 Oct 1.
4
Pathologic classification of cholangiocarcinoma: New concepts.胆管癌的病理分类:新概念
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):277-93. doi: 10.1016/j.bpg.2015.02.006. Epub 2015 Feb 17.
5
Potential targeted therapy for liver fluke associated cholangiocarcinoma.肝吸虫相关性胆管癌的潜在靶向治疗
J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):362-70. doi: 10.1002/jhbp.65. Epub 2014 Jan 10.
6
Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.肝内胆管癌合并原发性硬化性胆管炎患者的肿瘤分期与总生存期——一项回顾性队列研究
Z Gastroenterol. 2024 Jan;62(1):37-42. doi: 10.1055/a-2207-5519. Epub 2024 Jan 9.
7
Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.新辅助化疗治疗肝内、肝门周围和远端胆管癌:一项全国人群基于队列的比较研究。
J Gastrointest Surg. 2023 Apr;27(4):741-749. doi: 10.1007/s11605-023-05606-y. Epub 2023 Feb 7.
8
Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?双 HER2 阻断:转移性胆道癌的新选择?
Medicina (Kaunas). 2021 Nov 27;57(12):1301. doi: 10.3390/medicina57121301.
9
Emerging molecular therapeutic targets for cholangiocarcinoma.胆管癌的新兴分子治疗靶点。
J Hepatol. 2017 Sep;67(3):632-644. doi: 10.1016/j.jhep.2017.03.026. Epub 2017 Apr 5.
10
Clinical presentation, diagnosis and staging of cholangiocarcinoma.胆管癌的临床表现、诊断和分期。
Liver Int. 2019 May;39 Suppl 1:98-107. doi: 10.1111/liv.14086. Epub 2019 Mar 25.

引用本文的文献

1
Mitochondrial genomic alterations in cholangiocarcinoma cell lines.胆管癌细胞系中的线粒体基因组改变。
PLoS One. 2025 Jun 9;20(6):e0323844. doi: 10.1371/journal.pone.0323844. eCollection 2025.
2
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma.多区域全外显子组测序揭示华支睾吸虫相关胆管癌的肿瘤异质性。
Sci Rep. 2025 Mar 29;15(1):10886. doi: 10.1038/s41598-025-95142-3.
3
Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma.
胆管癌和肝细胞胆管癌起源细胞的形态分子病理学与基因组学见解
Am J Pathol. 2025 Mar;195(3):345-361. doi: 10.1016/j.ajpath.2024.08.014. Epub 2024 Sep 26.